Portfolio news 0

Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications

Quantum Motion Technologies

Quantum Motion Scientist and Professor M. Fernando Gonzalez Zalba Awarded Competitive ERC Consolidator Grant

Enterprise Therapeutics

Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis

First Light Fusion Ltd

First Light Fusion Awarded Key Contract to Help Advance UK Fusion Energy

Quantum Dice

EIC Accelerator backs Quantum Dice with €2m grant to advance probabilistic computing

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies Plc - Appointment of Francis Van Parys as Chief Executive Officer

Quantum Dice

Quantum Dice and STFC Hartree Centre join forces to bring quantum technology to industry

Mixergy Ltd

Mixergy pilots next-generation home energy system to support safer, compliant social housing

Istesso Ltd

Istesso provides updates on leramistat and next-generation programs

Artios Pharma

Artios announces oversubscribed $115m Series D financing to accelerate clinical programs in indications of high unmet need